BiotechTube
Home/Investors/The Column Group

The Column Group

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$3.8B
Focus Areas
5
Top Stage
Phase 3

Investment Focus

Neurodegenerative DiseasesLysosomal Storage DisordersCentral Nervous System (CNS)OncologyImmunology

Portfolio Companies

CompanyValuation
Denali Therapeutics$3.2B
Eikon Therapeutics$638.1M

Frequent Co-Investors

Fidelity2 sharedPublic shareholders1 sharedBiogen1 sharedTakeda1 sharedLux Capital1 sharedHorizons Ventures1 sharedAndreessen Horowitz1 sharedInnovation Endeavors1 shared